MLAB: Mesa Laboratories Inc Price to Sales

Symbol and logo of brand Mesa Laboratories Inc (MLAB)

The price-to-sales chart illustrates the market valuation of Mesa Laboratories, Inc. (MLAB), where 3.00 represents the latest metric reading. Growth is supported by mergers of filtration control companies and partnerships with pharmaceutical behemoths. Revenues are based on the sale of disinfection and calibration systems. A steady cash flow from the sale of consumables guarantees high margins and business liquidity.

MLAB (Mesa Labs) P/S Multiple history from 07/04/2022 to 11/13/2026

Analytical breakdowns for Mesa Labs Corp (MLAB)

- market price and analyst price targets:
Stock Quotes mesalabs.com|MLAB - Analyst Consensus Forecast
- market capitalization information:
Market Value Mesa Labs Corp|MLAB - Enterprise Value
- shareholders' equity book value data:
Equity per Share Mesa Labs|MLAB - Book Capitalization|Market Capitalization to Book Value mesalabs.com|MLAB - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Mesa Laboratories, Inc.|MLAB - Long-Term Debt to Capital|Short-Term Debt to Capital Mesa Laboratories Corp.|MLAB - Company Debts|Debt to Book Capitalization Ratio Mesa Labs Corp|MLAB - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Mesa Labs|Immediate Liquidity mesalabs.com
- net income and valuation multiples indicators:
MLAB - Company Net Income|Projected Net Profit Mesa Laboratories, Inc.|MLAB - Price to Earnings Ratio|Forward P/E Multiple Mesa Laboratories Inc|MLAB - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Mesa Labs Corp|MLAB - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Mesa Labs|MLAB - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months mesalabs.com|MLAB - Earnings growth in current year|Expected net earnings per share growth next year Mesa Laboratories, Inc.
- issuer revenue and sales details:
MLAB - Company Revenue|Company Revenue Forecast mesalabs.com|MLAB - Market Cap to Revenue|Price to Expected Revenue Ratio Mesa Labs Corp
Fundamental company analysis:mesalabs.com MLAB
Original product of Mesa Labs Corp

For Mesa Laboratories, Inc. (MLAB), the market capitalization-to-annual revenue ratio serves as an indicator for assessing revenue generation efficiency amid dependence on the cyclicality of pharmaceutical R&D budgets. By analyzing the P/S time series, an investor determines the premium for future growth and asset integration risks, allowing for a precise assessment of whether the current cost of capital is fair relative to actual equipment sales.

Who Mesa Laboratories, Inc. competes with

Market Cap to Revenue abbott.com ABT|P/S Multiple TMO (Thermo Fisher)|GE HealthCare Technologies Inc. (GEHC) - Price to Sales|Mettler-Toledo International Inc. - P/S Multiple|WAT (Waters Technologies) - Market Cap to Revenue Ratio|TECH: P/S Multiple|BRKR - Price-to-Revenue Coefficient|AZTA (Azenta) - P/S Multiple|Market Cap to Revenue Varex Imaging Corp (VREX)|P/S Multiple SMLR|P/S Multiple Butterfly Corp (BFLY)|Price-to-Revenue Ratio Quantum-Si QSI|nanox.vision - Price-to-Revenue Ratio|QTRX: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio MASS (908 Devices Inc)|CV: P/S Multiple|Price to Sales MaxCyte Inc (MXCT)|Price-to-Revenue Ratio Rapid Micro Biosystems Inc.|SEER - Price-to-Revenue Multiple|Market Cap to Revenue HYPR (Hyperfine)|P/S Multiple FONAR Corp. (FONR)|P/S Multiple DXR (Daxor)|Price-to-Revenue Coefficient spectral-ai.com (MDAI)|VIVS - Price-to-Revenue Ratio|Price-to-Sales Ratio ACON|akoyabio.com (AKYA) - Price-to-Revenue Ratio|Market Cap to Revenue ThermoGenesis Holdings, Inc.|TLIS (Talis Biomedical Corp.) - P/S Multiple|Price to Sales T2 Biosystems Inc TTOO